Home Podcasts PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

PVI, PeerView Institute for Medical Education 1011 Episodes Oct 13, 2026

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

Episodes

Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc) - Redefining Therapeutic Progress in HCC: Extending the Benefits of Immunotherapy to Earlier Stages of Disease
Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc) - Redefining Therapeutic Progress in HCC: Extending the Benefits of Immunotherapy to Earlier Stages of Disease Oct 13, 2026 00:28:08 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PEH865. CME/MOC/AAPA/IPCE credit will be available until Ju
Nikhil I. Khushalani, MD - The Next Act of Immunotherapy in CSCC: Upgrading the Risk-Adapted Management of Resectable Disease
Nikhil I. Khushalani, MD - The Next Act of Immunotherapy in CSCC: Upgrading the Risk-Adapted Management of Resectable Disease Oct 9, 2026 01:00:05 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DAP865. CME/MOC/AAPA/IPCE credit will be available until Oc
Prof. David Planchard, MD, PhD - From Data to Decisions in HER2-Overexpressing NSCLC: Detecting Alterations, Implementing Therapeutic Advances, and Navigating Practicalities of Care
Prof. David Planchard, MD, PhD - From Data to Decisions in HER2-Overexpressing NSCLC: Detecting Alterations, Implementing Therapeutic Advances, and Navigating Practicalities of Care Oct 9, 2026 00:58:49 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/EMJ865. CME/EBAC/AAPA/IPCE credit will be available until
Stephen V. Liu, MD - Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes
Stephen V. Liu, MD - Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes Oct 9, 2026 00:57:46 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/XSQ865. CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE credi
Robert W. Frenck Jr., MD / Flor M. Munoz, MD - Equitable Vaccination Practices for Pediatric and Adolescent Populations: Balancing Barriers, Bias, and Benefits
Robert W. Frenck Jr., MD / Flor M. Munoz, MD - Equitable Vaccination Practices for Pediatric and Adolescent Populations: Balancing Barriers, Bias, and Benefits Oct 9, 2026 01:05:09 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BTQ865. CME/MOC/AAPA/IPCE credit will be available until Se
Erika Hamilton, MD / Tiffany A. Traina, MD, FASCO - Practice Readiness for TROP2-Targeting ADCs in First-Line TNBC: Right Patient, Right Time, Right Team
Erika Hamilton, MD / Tiffany A. Traina, MD, FASCO - Practice Readiness for TROP2-Targeting ADCs in First-Line TNBC: Right Patient, Right Time, Right Team Oct 9, 2026 00:56:11 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NER865. CME/MOC/AAPA/IPCE credit will be available until Se
Pam R. Taub, MD, FACC, FASPC - Managing ASCVD From the Inside Out: Comprehensive Strategies for Getting the Most From Innovative Lipid-Lowering Therapies
Pam R. Taub, MD, FACC, FASPC - Managing ASCVD From the Inside Out: Comprehensive Strategies for Getting the Most From Innovative Lipid-Lowering Therapies Oct 5, 2026 00:52:25 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BMW865. CME credit will be available until September 28, 2027.Managing AS
William G. Wierda, MD, PhD - C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy
William G. Wierda, MD, PhD - C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy Oct 5, 2026 01:02:23 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SNH865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be
Charise Gleason, MSN, NP-C, AOCNP - MoDernizing RRMM Care: Oncology Nurse Perspectives on CELMoD Strategies and Principles for Sequential Therapy
Charise Gleason, MSN, NP-C, AOCNP - MoDernizing RRMM Care: Oncology Nurse Perspectives on CELMoD Strategies and Principles for Sequential Therapy Oct 5, 2026 00:35:30 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD information, and to apply for credit, please visit us at PeerView.com/ACX865. NCPD credit will be available until September 27, 2027.MoDernizi
Tuan H. Vu, MD - Generalized Myasthenia Gravis Across Serological Subtypes: Challenges in Diagnosis and Treatment Personalization
Tuan H. Vu, MD - Generalized Myasthenia Gravis Across Serological Subtypes: Challenges in Diagnosis and Treatment Personalization Oct 5, 2026 00:59:45 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/CVA865. CME/NCPD/AAPA credit will be available until September
Thomas S. Higgins, MD, MSPH, MBA - An Individualized Approach in CRSwNP: Precision Medicine in Action
Thomas S. Higgins, MD, MSPH, MBA - An Individualized Approach in CRSwNP: Precision Medicine in Action Sep 28, 2026 00:28:14 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/DAC865. CME/MOC/CC/AAPA credit will be available until Septem
Mario Castro, MD - Strategies for Incorporating Biologic Therapy Into Individualized COPD Treatment Plans
Mario Castro, MD - Strategies for Incorporating Biologic Therapy Into Individualized COPD Treatment Plans Sep 28, 2026 00:23:40 This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YKV865. CME/MOC/AAPA credit will be available until September 10

Recommended